Skip to main content
Clinical Trials/NCT03350555
NCT03350555
Unknown
Not Applicable

Validation of Clinical Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography

Changhai Hospital1 site in 1 country40 target enrollmentNovember 2017
ConditionsERCP

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ERCP
Sponsor
Changhai Hospital
Enrollment
40
Locations
1
Primary Endpoint
Duration of ERCP treatment
Last Updated
8 years ago

Overview

Brief Summary

Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.

Detailed Description

Investigators recently developed a device named additioned Endoscopy. The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.

Registry
clinicaltrials.gov
Start Date
November 2017
End Date
December 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiangyu Kong

Doctor of gastroenterology department

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • People who are indicated to ERCP treatment.

Exclusion Criteria

  • People who are not suitable for ERCP treatment.

Outcomes

Primary Outcomes

Duration of ERCP treatment

Time Frame: Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient

To test if additioned endoscopy will have impact on duration of ERCP treatment

Secondary Outcomes

  • complications of ERCP treatment(up to 1 month after ERCP completion)

Study Sites (1)

Loading locations...

Similar Trials